200 related articles for article (PubMed ID: 27734602)
1. Recurrent heparin-induced thrombocytopenia due to heparin rinsing before priming the machine in a hemodialysis patient: A case report.
Lim JH; Kang KP; Lee S; Park SK; Kim W
Hemodial Int; 2017 Apr; 21(2):E30-E33. PubMed ID: 27734602
[TBL] [Abstract][Full Text] [Related]
2. Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD.
Dager WE; White RH
Ann Pharmacother; 2003 Sep; 37(9):1232-6. PubMed ID: 12921505
[TBL] [Abstract][Full Text] [Related]
3. Fondaparinux therapy in a hemodialysis patient with heparin-induced thrombocytopenia type II.
Wellborn-Kim JJ; Mitchell GA; Terneus WF; Stowe CL; Malias MA; Sparkman GM; Hanson GW
Am J Health Syst Pharm; 2010 Jul; 67(13):1075-9. PubMed ID: 20554593
[TBL] [Abstract][Full Text] [Related]
4. Concomitant use of argatroban and warfarin during hemodialysis in heparin-induced thrombocytopenia.
Vianello F; Furian L; Nordio M; Treleani M; Fabris F
Hematology; 2015 Jan; 20(1):48-9. PubMed ID: 24580134
[TBL] [Abstract][Full Text] [Related]
5. Heparin-induced thrombocytopenia: when a low platelet count is a mandate for anticoagulation.
Ortel TL
Hematology Am Soc Hematol Educ Program; 2009; ():225-32. PubMed ID: 20008202
[TBL] [Abstract][Full Text] [Related]
6. Heparin-induced thrombocytopenia in patients administered heparin solely for hemodialysis.
Murray PT; Hursting MJ
Ren Fail; 2006; 28(7):537-9. PubMed ID: 17050234
[TBL] [Abstract][Full Text] [Related]
7. [Patient who developed heparin-induced thrombocytopenia type II after 24 years on hemodialysis].
Gavranić BB; Basić-Jukić N; Kes P
Acta Med Croatica; 2012 Oct; 66 Suppl 2():68-71. PubMed ID: 23513420
[TBL] [Abstract][Full Text] [Related]
8. Heparin-induced thrombocytopenia complicating hemodialysis.
Barginear MF; Donahue L; Allen SL; Budman DR; Bradley T; Bhaskaran M; Shapira I
Clin Appl Thromb Hemost; 2008 Jan; 14(1):105-7. PubMed ID: 18160608
[TBL] [Abstract][Full Text] [Related]
9. Heparin-induced thrombocytopenia in a hemodialysis patient treated with fondaparinux: nephrologists between two fires.
Solak Y; Demircioglu S; Polat I; Biyik Z; Gaipov A; Acar K; Turk S
Hemodial Int; 2013 Apr; 17(2):320-3. PubMed ID: 22631215
[TBL] [Abstract][Full Text] [Related]
10. [Heparin-induced thrombocytopenia (HIT): pathogenesis, laboratory test, and treatment].
Matsuo T; Wanaka K; Asada R
Rinsho Byori; 2005 Jul; 53(7):622-9. PubMed ID: 16104531
[TBL] [Abstract][Full Text] [Related]
11. Use of argatroban during percutaneous coronary interventions in patients with heparin-induced thrombocytopenia.
Matthai WH
Semin Thromb Hemost; 1999; 25 Suppl 1():57-60. PubMed ID: 10357153
[TBL] [Abstract][Full Text] [Related]
12. Intravenous warfarin and heparin-induced thrombocytopenia: making the diagnosis, management, modern monitoring, and multidisciplinary care.
Burger CF; Schlesinger JJ
Ann Pharmacother; 2014 Feb; 48(2):286-91. PubMed ID: 24259642
[TBL] [Abstract][Full Text] [Related]
13. [Anesthesia for a hemodialysis patient with HIT undergoing CABG using argatroban].
Goto S; Hiramori T; Kuroiwa K; Mochizuki N; Takano T; Nishizawa M
Masui; 2012 Apr; 61(4):397-9. PubMed ID: 22590944
[TBL] [Abstract][Full Text] [Related]
14. Heparin-induced thrombocytopenia in a pediatric patient receiving extracorporeal support and treated with argatroban.
Scott LK; Grier LR; Conrad SA
Pediatr Crit Care Med; 2006 May; 7(3):255-7. PubMed ID: 16474254
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic implications of heparin-induced thrombocytopenia complicating acute hemodialysis.
Roncon-Albuquerque R; Beco A; Ferreira AL; Gomes-Carvalho C; Costa A; Frazão J; Pestana M; von Hafe P
Clin Nephrol; 2010 Apr; 73(4):326-30. PubMed ID: 20353743
[TBL] [Abstract][Full Text] [Related]
16. Use of argatroban as a procedural and bridging anticoagulant in a patient undergoing carotid endarterectomy with concomitant atrial fibrillation.
Nanda MM; Kauflin MJ; Jain PG; Yannetta JC
Ann Pharmacother; 2011 Mar; 45(3):e16. PubMed ID: 21386022
[TBL] [Abstract][Full Text] [Related]
17. Argatroban anticoagulation for heparin-induced thrombocytopenia in elderly patients.
Bartholomew JR; Pietrangeli CE; Hursting MJ
Drugs Aging; 2007; 24(6):489-99. PubMed ID: 17571914
[TBL] [Abstract][Full Text] [Related]
18. [Clinical observation of heparin-induced thrombocytopenia].
Tian HY; Meng Y; Zhang JB; Ma Q; Cheng GS; Fan FL; Wang J; Wan HM
Zhonghua Yi Xue Za Zhi; 2009 May; 89(20):1405-7. PubMed ID: 19671335
[TBL] [Abstract][Full Text] [Related]
19. [Heparin-induced trombocytopenia: pathogenesis, clinical manifestations and management in hemodialysis].
Esposito P; Libetta C; Borettaz I; Barone M; Canevari M; Martinelli C; Montagna F; Romeo S; Margiotta E; Calatroni M; La Porta E; Dal Canton A
G Ital Nefrol; 2014; 31(3):. PubMed ID: 25030007
[TBL] [Abstract][Full Text] [Related]
20. Anti-neutrophil cytoplasmic antibody-associated vasculitis accompanied by type II heparin-induced thrombocytopenia resulting in asymptomatic cerebral infarction: a case report.
Furuto Y; Kawamura M; Yamashita J; Yoshikawa T; Namikawa A; Isshiki R; Takahashi H; Shibuya Y
BMC Nephrol; 2021 Jun; 22(1):220. PubMed ID: 34126959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
